MRVI

3.76

2.17% 0.08

Dopo l'orario di chiusura: 3.76

Maravai Lifesciences Holdings Inc (MRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MRVI Giù? Forum Previsione

Precedente Chiudi:

$3.68

Aprire:

$3.7

Volume 24 ore:

1.19M

Relative Volume:

0.81

Capitalizzazione di mercato:

$545.29M

Reddito:

$288.95M

Utile/perdita netta:

$-119.03M

Rapporto P/E:

-4.1755

EPS:

-0.9005

Flusso di cassa netto:

$60.67M

1 W Prestazione:

+3.87%

1M Prestazione:

+10.26%

6M Prestazione:

+69.37%

1 anno Prestazione:

-28.92%

Intervallo 1D:

$3.62

$3.78

Intervallo di 1 settimana:

$3.37

$3.80

Portata 52W:

$1.665

$6.21

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Nome

Maravai Lifesciences Holdings Inc

Settore

Healthcare (1134)

Industria

Biotechnology (635)

Telefono

(858) 546-0004

Indirizzo

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Dipendente

550

Cinguettio

Prossima data di guadagno

2025-03-18

Ultimi documenti SEC

MRVI's Discussions on Twitter

Confronta MRVI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MRVI Maravai Lifesciences Holdings Inc	3.76	533.68M	288.95M	-119.03M	60.67M	-0.9005
VRTX Vertex Pharmaceuticals Inc	429.82	107.58B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.32	80.03B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	429.80	57.37B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	917.93	55.83B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	209.02	44.13B	447.02M	-1.18B	-906.14M	-6.1812

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2024-12-19	Iniziato	Guggenheim	Neutral
2024-12-05	Downgrade	Goldman	Neutral → Sell
2024-11-14	Iniziato	Wolfe Research	Peer Perform
2024-11-08	Downgrade	William Blair	Outperform → Mkt Perform
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-08-13	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Iniziato	Craig Hallum	Buy
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-08-08	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Downgrade	Credit Suisse	Outperform → Neutral
2023-05-09	Downgrade	Goldman	Buy → Neutral
2023-01-05	Downgrade	UBS	Buy → Neutral
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-11-03	Downgrade	BofA Securities	Buy → Neutral
2022-08-25	Iniziato	Credit Suisse	Outperform
2021-08-05	Ripresa	Credit Suisse	Outperform
2020-12-16	Iniziato	KeyBanc Capital Markets	Overweight
2020-12-15	Iniziato	BofA Securities	Buy
2020-12-15	Iniziato	Credit Suisse	Outperform
2020-12-15	Iniziato	Goldman	Buy
2020-12-15	Iniziato	Jefferies	Buy
2020-12-15	Iniziato	Robert W. Baird	Outperform
2020-12-15	Iniziato	Stifel	Buy
2020-12-15	Iniziato	William Blair	Outperform
2020-12-14	Iniziato	UBS	Buy

Mostra tutto

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

Nov 24, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review

Nov 24, 2025

Nov 23, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

Nov 23, 2025

Nov 21, 2025

Is Maravai LifeSciences Holdings Inc. (MAR) stock undervalued at current priceMarket Weekly Review & AI Driven Price Predictions - newser.com

Nov 21, 2025

Published on: 2025-11-21 05:22:01 - newser.com

Nov 21, 2025

Will Maravai LifeSciences Holdings Inc. stock outperform value stocksQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

Nov 21, 2025

Nov 20, 2025